
Photo: Reuters
SYDNEY (Reuters) - Asian shares were mixed on Thursday after a choppy day of Wall Street trade, thanks in part to a disappointing U.S. jobs report, while the greenback languished near 2-1/2 year lows on growing optimism of a coronavirus vaccine.
Britain became the first Western country to approve a COVID-19 vaccine, with 800,000 doses of the Pfizer and BioNTech vaccine available for those at high risk starting next week.
The U.S. Food and Drug Administration is holding its advisory committee meeting next week, while New York Governor Andrew Cuomo has said the state's first delivery, enough for 170,000 residents, is expected on Dec 15.
The dollar index slipped to two-and-half year low of 90.987 on Wednesday and last stood at 91.048.
Hopes of a fiscal support package in the United States also boosted investor optimism. But share traders were less enthused.
MSCI's broadest index of Asia-Pacific shares outside of Japan were barely changed following two straight days of gains.
Japan's Nikkei was 0.2% weaker while South Korea's KOSPI was flat and Australia's benchmark index was slightly higher.
Chinese shares opened a tad lower, with the blue-chip CSI300 index off 0.03%.
Read more from the original article here:
風險提示:本文所述僅代表作者個人觀點,不代表 Followme 的官方立場。Followme 不對內容的準確性、完整性或可靠性作出任何保證,對於基於該內容所採取的任何行為,不承擔任何責任,除非另有書面明確說明。

暫無評論,立馬搶沙發